|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Gross profit (loss) | |||||
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Sales and marketing | |||||
| Foreign exchange loss (gain) | |||||
| Depreciation and amortization (note 9) | |||||
| Loss on sale of assets | |||||
| Impairment of long-lived assets (note 9) | |||||
| Cost of revenue and expenses | |||||
| Loss from continuing operations | |||||
| Loss from investments accounted for by the equity method (notes 8 and 17) | |||||
| Gain on deconsolidation | |||||
| Loss on sale of investment | |||||
| Loss on extinguishment of royalty payable | |||||
| Interest on long-term debt and accretion of royalty payable | |||||
| Impairment of long-term investment | |||||
| Other income, net | |||||
| Interest and other income, net of bank charges | |||||
| Loss before income taxes | |||||
| Income tax expense (recovery) (note 14(a)): | |||||
| Current | |||||
| Deferred | |||||
| Income tax expense (recovery) | |||||
| Net loss from continuing operations | |||||
| Net income (loss) from discontinued operations (note 5) | |||||
| Net loss for the year | |||||
| Other comprehensive income (loss): | |||||
| Cumulative translation adjustment | |||||
| Reclassification of accumulated foreign currency translation on deconsolidation | |||||
| Ownership share of equity method investments' other comprehensive loss | |||||
| Other comprehensive income (loss) | |||||
| Comprehensive loss | |||||
| Loss per share: | |||||
| From continuing operations - basic (in dollars per share) | |||||
| From continuing operations - diluted (in dollars per share) | |||||
| From discontinued operations - basic (in dollars per share) | |||||
| From discontinued operations - diluted (in dollars per share) | |||||
| Net loss per share, basic (in dollars per share) | |||||
| Net loss per share, diluted (in dollars per share) | |||||
| Weighted average common shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...